Search research articles
Contact Us
Filters
Showing results (11-20 of 83) with videos related to
Page
of 9
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 26, 2016
Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3
Dorit Di Gioia, Irene Blankenburg, Dorothea Nagel, et al.
Annals of the New York Academy of Sciences
|
October 8, 2008
DNA integrity in plasma and serum of patients with malignant and benign diseases
Stefan Holdenrieder, Alexander Burges, Oliver Reich, et al.
Anticancer Research
|
May 18, 2012
Nature and dynamics of nucleosome release from neoplastic and non-neoplastic cells
Stefan Holdenrieder, Frank T Kolligs, Jan Braess, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 10, 2005
Nucleosomes in pancreatic cancer patients during radiochemotherapy
Andreas Kremer, Ralf Wilkowski, Stefan Holdenrieder, et al.
Onkologie
|
February 1, 2007
Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy?
Stefan Boeck, Christoph Schulz, Petra Stieber, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 26, 2006
Nucleosomes in colorectal cancer patients during radiochemotherapy
Andreas Kremer, Stefan Holdenrieder, Petra Stieber, et al.
BMC Cancer
|
May 28, 2011
Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
September 21, 2011
Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy
Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, et al.
Anticancer Research
|
June 3, 2006
Evaluation of CK8-specific autoantibodies in carcinomas of distinct localisations
Martin Ahlemann, Bärbel Schmitt, Petra Stieber, et al.
Cancer Immunology, Immunotherapy : CII
|
April 26, 2006
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA
Stefan Holdenrieder, Petra Stieber, Andrea Peterfi, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 83) with videos related to
Sort By:
Page
of 9
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 26, 2016
Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3
Dorit Di Gioia, Irene Blankenburg, Dorothea Nagel, et al.
Annals of the New York Academy of Sciences
|
October 8, 2008
DNA integrity in plasma and serum of patients with malignant and benign diseases
Stefan Holdenrieder, Alexander Burges, Oliver Reich, et al.
Anticancer Research
|
May 18, 2012
Nature and dynamics of nucleosome release from neoplastic and non-neoplastic cells
Stefan Holdenrieder, Frank T Kolligs, Jan Braess, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 10, 2005
Nucleosomes in pancreatic cancer patients during radiochemotherapy
Andreas Kremer, Ralf Wilkowski, Stefan Holdenrieder, et al.
Onkologie
|
February 1, 2007
Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy?
Stefan Boeck, Christoph Schulz, Petra Stieber, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 26, 2006
Nucleosomes in colorectal cancer patients during radiochemotherapy
Andreas Kremer, Stefan Holdenrieder, Petra Stieber, et al.
BMC Cancer
|
May 28, 2011
Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
September 21, 2011
Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy
Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, et al.
Anticancer Research
|
June 3, 2006
Evaluation of CK8-specific autoantibodies in carcinomas of distinct localisations
Martin Ahlemann, Bärbel Schmitt, Petra Stieber, et al.
Cancer Immunology, Immunotherapy : CII
|
April 26, 2006
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA
Stefan Holdenrieder, Petra Stieber, Andrea Peterfi, et al.
Page
of 9